Refametinib 25mg 25mg | Purity Not Available
Adooq Bioscience
Refametinib is a potent, ATP non-competitive and highly selective inhibitor of MEK1 and MEK2 with IC50 of 19 nM and 47 nM, respectively.
More Information Supplier PageSearch Results
Refametinib 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
Refametinib is a potent, ATP non-competitive and highly selective inhibitor of MEK1 and MEK2 with IC50 of 19 nM and 47 nM, respectively.
More Information Supplier PageRefametinib 10mg 10mg | Purity Not Available
Adooq Bioscience
Refametinib is a potent, ATP non-competitive and highly selective inhibitor of MEK1 and MEK2 with IC50 of 19 nM and 47 nM, respectively.
More Information Supplier PageBMS-690514 50mg 50mg | Purity Not Available
Adooq Bioscience
BMS-690514 is a potent and selective inhibitor of epidermal growth factor receptor (EGFR), HER2, and HER4, as well as the VEGF receptor kinases.
More Information Supplier PageBMS-690514 5mg 5mg | Purity Not Available
Adooq Bioscience
BMS-690514 is a potent and selective inhibitor of epidermal growth factor receptor (EGFR), HER2, and HER4, as well as the VEGF receptor kinases.
More Information Supplier PageBMS-690514 25mg 25mg | Purity Not Available
Adooq Bioscience
BMS-690514 is a potent and selective inhibitor of epidermal growth factor receptor (EGFR), HER2, and HER4, as well as the VEGF receptor kinases.
More Information Supplier PageBMS-690514 10mg 10mg | Purity Not Available
Adooq Bioscience
BMS-690514 is a potent and selective inhibitor of epidermal growth factor receptor (EGFR), HER2, and HER4, as well as the VEGF receptor kinases.
More Information Supplier PageGW842166X 10mg 10mg | Purity Not Available
Adooq Bioscience
GW842166X is a selective non-cannabinoid CB2 receptor agonist, which is undergoing clinical development as a novel oral treatment for inflammatory pain
More Information Supplier PageXL-888 50mg 50mg | Purity Not Available
Adooq Bioscience
XL888 is an orally bioavailable, ATP-competitive, small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity.
More Information Supplier PageXL-888 5mg 5mg | Purity Not Available
Adooq Bioscience
XL888 is an orally bioavailable, ATP-competitive, small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity.
More Information Supplier Page